Primary gastrointestinal stromal tumour of the ileum pre-operatively diagnosed as an abdominal abscess

Rubini,Patrizia; Tartamella,Francesco

doi:10.3892/mco.2016.1009

Primary gastrointestinal stromal tumour of the ileum pre-operatively diagnosed as an abdominal abscess

Authors:
- Patrizia Rubini
- Francesco Tartamella
View Affiliations

Affiliations: Department of Surgery, Institute of General Surgery, University of Parma, I‑43100 Parma, Italy
Published online on: September 2, 2016 https://doi.org/10.3892/mco.2016.1009
Pages: 596-598

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present case report described the acute presentation, diagnosis and management of a primary gastrointestinal stromal tumour (GIST) of the ileum. A male patient (age, 51 years) was admitted to Maggiore Hospital (Parma, Italy) due to presenting with fever, dysuria and lower abdominal pain. Ultrasonography and computed tomography showed a 7,5x5,5‑cm pelvic mass containing air and purulent fluid indicative of an intraperitoneal abscess. The patient was subjected to diagnostic laparoscopy, which revealed a huge, soft cystic mass arising from the small bowel. The procedure was then converted to an open exploration through a midline incision. Ileal resection including a Meckel's diverticulum was performed. Macroscopic examination revealed that the cystic mass was filled with a large amount of pus, probably due to communication between the tumour mass and the small bowel lumen. In fact, the surgical specimen showed enteric leakage from the ileal mucosal ulcer into the tumour mass. Histopathology and immunohistochemistry of the abscess wall identified a spindle‑cell mesenchymal‑type, c‑KIT‑positive neoplasm. The post‑operative course was uneventful and adjuvant imatinib mesylate was administered for 1 year. Follow‑up by computed tomography demonstrated no tumour recurrence at 72 months after surgery.

View Figures

View References

1	Kindblom LG, Remotti HE, Aldenborg F and Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 152:1259–1269. 1998.PubMed/NCBI
2	Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 279:577–580. 1998. View Article : Google Scholar : PubMed/NCBI
3	Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, et al: PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 299:708–710. 2003. View Article : Google Scholar : PubMed/NCBI
4	Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, et al: Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 347:472–480. 2002. View Article : Google Scholar : PubMed/NCBI
5	Tran T, Devila JA and El-Serag HB: The epidemiology of malignant gastrointestinal stromal tumors: An analysis of 1,458 cases from 1992 to 2000. Am J Gastroenterol. 100:162–168. 2005. View Article : Google Scholar : PubMed/NCBI
6	Miettinen M and Lasota J: Gastrointestinal stromal tumors: Review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 130:1466–1478. 2006.PubMed/NCBI
7	Miettinen M, Makhlouf H, Sobin LH and Lasota J: Gastrointestinal stromal tumors of the jejunum and ileum: A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 30:477–489. 2006. View Article : Google Scholar : PubMed/NCBI
8	Lord C, Ozgediz D and Cohen MJ: Image of the month. Gastrointestinal stromal tumor. Arch Surg. 144:87–88. 2009. View Article : Google Scholar : PubMed/NCBI
9	Efremidou EI, Liratzopoulos N, Papageorgiou MS and Romanidis K: Perforated GIST of the small intestine as a rare cause of acute abdomen: Surgical treatment and adjuvant therapy. Case report. J Gastrointestin Liver Dis. 15:297–299. 2006.PubMed/NCBI
10	Bardell T, Jalink DW, Hurlbut DJ and Mercer CD: Gastrointestinal stromal tumour: Varied presentation of a rare disease. Can J Surg. 49:286–289. 2006.PubMed/NCBI
11	Chen HW and Lin TY: Tumor abscess formation caused by Morganella morganii complicated with bacteremia in a patient with gastrointestinal stromal tumor. Clin Res Hepatol Gastroenterol. 36:e29–e31. 2012. View Article : Google Scholar : PubMed/NCBI
12	Karagülle E, Türk E, Yildirim E, Gõktürk HS, KiYici H and Moray G: Multifocal intestinal stromal tumors with jejunal perforation and intra-abdominal abscess: Report of a case. Turk J Gastroenterol. 19:264–267. 2008.PubMed/NCBI
13	Dow N, Giblen G, Sobin LH and Miettinen M: Gastrointestinal stromal tumors: Differential diagnosis. Semin Diagn Pathol. 23:111–119. 2006. View Article : Google Scholar : PubMed/NCBI
14	Rubin BP: Gastrointestinal stromal tumours: An update. Histopathology. 48:83–96. 2006. View Article : Google Scholar : PubMed/NCBI
15	Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, et al: Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol. 33:459–465. 2002. View Article : Google Scholar : PubMed/NCBI
16	Miettinen M and Lasota J: Gastrointestinal stromal tumors: Pathology and prognosis at different sites. Semin Diagn Pathol. 23:70–83. 2006. View Article : Google Scholar : PubMed/NCBI
17	Takahashi T, Nakajima K, Nishitani A, Souma Y, Hirota S, Sawa Y and Nishida T: An enhanced risk-group stratification system for more practical prognostication of clinically malignant gastrointestinal stromal tumors. Int J Clin Oncol. 12:369–374. 2007. View Article : Google Scholar : PubMed/NCBI